'BioConversations'
Empowering Sustainable Urban Mobility: Biocon at the Yellow Line Inauguration When Bhavya Nair, Senior Scientist, and Padmapriya, Principal Scientist, were chosen to represent Biocon at the inauguration of Bengaluru’s Yellow Line Metro by Hon’ble Prime Minister Narendra Modi, they described the experience as nothing short of “surreal.” From the anxious wait before the ceremony, to … Continue reading A Surreal Ride: Biocon Scientists Share Their Yellow Line Metro Inauguration Experience
The launch of the much-awaited Yellow Line Metro feels nothing short of a festival for Bengalureans, especially those who live in or commute to and from Electronic City. Spanning 19.15 km from Bommasandra to RV Road, the Yellow Line links Electronic City to the heart of Bengaluru, promising faster, greener, and more convenient travel. The … Continue reading PM Narendra Modi recognizes Biocon and other Corporates for Contribution towards the Yellow Line Metro
Biocon has kicked off FY26 with confidence and is building momentum, setting the tone for a robust year ahead. Powered by strong gains in Biosimilars, steady growth in CRDMO, and a resilient performance in Generics, the quarter reflects more than just numbers, it's a testament to the company's ability to adapt to change and seize … Continue reading Biocon Q1FY26 Earnings is well-positioned for contined momentum and sustained growth
Today, we have a special conversation with Dr. Praveen Raj, Head of Medical Affairs, who recently represented Biocon Biologics at the prestigious International Diabetes Federation (IDF) Congress. IDF is a global platform where researchers, clinicians, and industry leaders from around the world share the latest advancements in diabetes care. This year, Biocon Biologics presented six … Continue reading In Conversation with Dr. Praveen Raj for IDF, Thailand
Biocon Foundation’s unique public art project transforms the space under the elevated corridor of the Biocon-Hebbagodi Metro Station When you close your eyes and try to picture the roads of Bengaluru, what do you see? Do you see a traffic policeman frantically waving his hands, signalling vehicles to keep moving? Do you see an IT … Continue reading Pillars of Bengaluru: A Heartfelt Tribute to Everyday Champions
Summary: Biosimilars present unique development challenges, but the Mass Spectrometry-based Multi-Attribute Method (MAM) offers a deeper understanding of molecule attributes by analyzing multiple factors in a single workflow. This advanced technique ensures efficient analysis, reduces variability, and maintains the consistent quality and safety of biosimilars. Biological medicines (biopharmaceutical) have transformed the way we treat chronic … Continue reading Navigating the Complexities of Peaks and Attributes in Biopharmaceuticals Using Mass Spectrometry-based Multi-Attribute Method (MAM)
The Bengaluru Tech Summit 2024 (BTS 2024), held from November 19-21 under the aegis of the Government of Karnataka, marked its 27th edition this year. The summit brought together luminaries from diverse fields such as Biotech, HealthTech, SpaceTech, GreenTech, FinTech, DeepTech, and Mobility, creating a platform to discuss and explore sustainable solutions to humanity’s most … Continue reading Bengaluru Tech Summit 2024: Biocon Group Showcases Leadership in Biotech Innovation
Diabetes continues to pose a significant global health challenge, particularly in low- and middle-income countries (LMICs) like Ethiopia. With a prevalence rate of 2–3%, Ethiopia ranks among the top four countries in sub-Saharan Africa for diabetes cases, contributing to nearly 2% of all deaths in the country. Despite these alarming statistics, the nation faces a … Continue reading Bridging the Gap in Diabetes Care by Upskilling Nurses in Ethiopia
The nation has lost a legendary visionary who has inspired billions across the world. Ratan Tata's exemplary journey is defined by his unwavering commitment to his country and its people. His leadership transcended industries, impacting lives through job creation, innovative solutions, and philanthropy. He truly carried forward the Tata legacy.At Biocon Group, we pay our … Continue reading Heartfelt Tributes to the Legendary Mr. Ratan Tata, Who Will Continue to Inspire Billions for Decades
Biocon Group participated at the recently concluded Global Bio-India 2024 (GBI 2024), a Government of India initiative under the Department of Biotechnology. The 4th Edition of the GBI 2024, held during September 12-14 in New Delhi witnessed a large representation from key stakeholders in the biotechnology sector, demonstrating India’s biotech potential to the world. In … Continue reading Global Bio India 2024: Biocon Group Playing a Critical Role in Realizing India’s Bioeconomy Potential
Biocon Biologics proudly celebrated a significant milestone with the official opening of its new North America headquarters in Bridgewater, New Jersey, on Friday, September 13. This occasion also marked the Company’s first-year anniversary in the region, further solidifying its commitment to providing high-quality, affordable biosimilar medicines to patients in North America and across the globe. … Continue reading Biocon Biologics Opens North America Headquarters in New Jersey’s Biopharma Corridor
The successful integration of the acquired Biosimilars business dominated the Biocon Biologics growth story last year. In fiscal year 2024-25 (FY25), we have turned our focus to consolidating the acquired business and paving the way for future growth. Our performance in the first quarter of FY25 gives us confidence that we are on the right … Continue reading Biocon Biologics off to a solid start in Q1 FY25, powered byproduct sales & market shares
Agnostic of the gender, leadership qualities come from passion, vision, and foresight for ushering meaningful changes for a better tomorrow. For a leader to lead, it is the leadership quality that takes precedence over the binary of gender. Celebrating Women’s Day and Making Each One Count In a display of great camaraderie and participation, Biocon … Continue reading Biocon Biologics Commemorates International Women’s Day 2024 with a Focus on Diversity & Inclusion
Women have long defied boundaries and shattered gender stereotypes, embarking on journeys to seize control of their lives by navigating challenges and taking control of their destinies. Cherishing a legacy of 45 years, Biocon group traces its roots to a brainchild of young and confident Ms Kiran Mazumdar-Shaw whose indomitable spirit led to the setting … Continue reading Agents of Change, Women bring Value to Science
By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics In the Interim Union Budget 2024-25, Finance Minister Nirmala Sitharaman has provided a comprehensive roadmap for sustained economic growth that will enable India to achieve a developed economy status by 2047. The global economy went through a volatile period between 2020 and 2023. However, India’s GDP … Continue reading A Vision of ‘Viksit Bharat’, Driven by Inclusion & Innovation
Know Bengaluru Tech Summit Bengaluru Tech Summit (BTS) is a platform for knowledge sharing, discussions, best industry practices, transformative insights and thought leadership to the stakeholders and participants, covering various gamut of technologies, innovation and entrepreneurship. The three-day event was inaugurated by Karnataka Chief Minister Siddaramaiah on November 29, 2023, at the Bangalore Palace. … Continue reading Govt Support in Fundamental Research key to make India a truly knowledge based Economy
What Drives Corporate Reputation of a Pharma Brand? A new film has released, and you can’t make up your mind whether it’s worth your time and money. What do you do? Well, reading some reviews might help, or maybe a recommendation from a friend. In either instance, you decision would be based on the reputation … Continue reading What Drives Corporate Reputation of a Pharma Brand?
Biocon Biologics marked a key milestone in the post-acquisition integration of the biosimilars business of its long-term partner Viatris with the successful transitioning of the business in North America (United States and Canada) on September 1, 2023. It marks Biocon Biologics’ first direct commercial presence in Advanced Markets and represents the largest share of its … Continue reading Biocon Biologics Marks Another Key Milestone with Successful Transition of the North America Business Ahead of Plan
A Blog by Biocon 